Agreement on the prescription of antimicrobial drugs

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Casaroto, Eduardo ^a   Marra, Alexandre R ^a   Camargo, Thiago Zinsly Sampaio ^a   de Souza, Ana Rita Araújo ^a   de Almeida, Carlos Eduardo Saldanha ^a   Pedroti, Elizia Piassi ^a   Victor, Elivane da Silva ^a   dos Santos, Oscar Fernando Pavão ^a   Edmond, Michael B ^b   Campos, Alexandre Holthausen ^a  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Antimicrobial therapy; Empirical therapy; Infectious diseases

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; MACROLIDE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; BRAZIL; E-MAIL; FEMALE; HOSPITALIZATION; HUMAN; INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MONOTHERAPY; PHYSICIAN; PRESCRIPTION; SEPSIS; VERY ELDERLY; COMMUNICABLE DISEASES; HOSPITAL; MIDDLE AGED; STANDARDS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES; DRUG PRESCRIPTIONS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PHYSICIANS; YOUNG ADULT;

EID: 84933506702     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0992-y     Document Type: Article

References (24)

1. Textoris J, Wiramus S, Martin C, Leone M. Overview of antimicrobial therapy in intensive care units. Expert Rev Anti-Infect Ther. 2011;9:97-109.
2. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA. 2009;302:2323-9.
3. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections - A risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462-74.
4. Isturiz RE. Optimizing antimicrobial prescribing. Int J Antimicrob Agents. 2010;36 suppl 3:S19-22.
5. Sader HS, Farrell DJ, Flamm RK, Jones RN. Antimicrobial susceptibility of gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011). Diagn Microbiol Infect Dis. 2014;78:443-8.
6. Marra AR, de Almeida SM, Correa L, Silva Jr M, Martino MD, Silva CV, et al. The effect of limitation antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control. 2009;37:204-9.
7. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: International Guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637.
8. Rimawi RH, Mazer MA, Siraj DS, Gooch M, Cook PP. Impact of regular collaboration between infectious diseases and critical care practitioners on antimicrobial utilization and patient outcome. Crit Care Med. 2013;41:2099-107.
9. Jong EA, Lange DW, van Oers JA, Nijsten MW, Twisk JW, Beishuizen A. Stop antibiotics on guidance of procalcitonin study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients - calculated sample size: 1816 patients. BMC Infect Dis. 2013;13:178.
10. De Waele JJ, Ravyts M, Depuydt P, Blot SI, Decruyenaere J, Vogelaers D. De-escalonation after empirical meropenem treatment in the intensive care unit: Fiction or reality? J Crit Care. 2010;25:641-6.
11. Allegranzi B, Luzzati R, Luzzani A, Girardini F, Antozzi L, Raiteri R, et al. Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. J Hosp Infect. 2002;52:136-40.
12. Thu TA, Rahman M, Coffin S, Harun-Or-Rashid M, Sakamoto J, Hung NV. Antibiotic use in Vietnamese hospitals: A multicenter point-prevalence study. Am J Infect Control. 2012;40:840-4.
13. Hulscher MEJL, Grol RPTM, van der Meer JWM. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010;10:167-75.
14. Hranjec T, Sawyer RG. Conservative initiation of antimicrobial treatment in ICU patients with suspected ICU-acquired infection: more haste less speed. Curr Opin Crit Care. 2013;19:461-4.
15. Charani E, Edwards R, Sevdalis N, Alexandrou B, Sibley E, Mullet D, et al. Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review. Clin Infect Dis. 2011;53:651-62.
16. Cairns KA, Jenney AW, Abbott IJ, Skinner MJ, Doyle JS, Dooley M, et al. Prescribing trends before and after implementation of an antimicrobial stewardship program. Med J Aust. 2013;198:262-6.
17. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:1-36.
18. Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernández-Delgado E, Herrera-Melero I, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014;40:32-40.
19. Braykov NP, Morgan DJ, Schweizer ML, Uslan DZ, Kelesidis T, Weisenberg SA, et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis. 2014;14:1220-7.
20. Vincent JL, Moreno R, Takala J, Willats S, De Mendonca A, Bruining H, et al. The SOFA score to describe organ dysfunction/failure. Intensive Care Med. 1996;22:707-10.
21. Wang KY, Seed P, Schofield P, Ibrahim S, Ashworth M. Which practices are high antibiotic prescribers? A cross-sectional analysis. Br J Gen Pract. 2009;59:e315-20.
22. Sintchenko V, Coiera E, Gilbert GL. Decision support systems for antibiotic prescribing. Curr Opin Infect Dis. 2008;21:573-9.
23. Kollef MH. Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000;31 suppl 4:S131-8.
24. Yokota PKO, Marra AR, Martino MDV, Victor ES, Durão MS, Edmond MB, Santos OFP. Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock - a quality improvement study. In press: PLoS One 2014.